Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab in hospitalized COVID-19 patients
NCT04920916Phase 2Completed
- Sponsor
- University of Virginia
- Start
- May 2021
- Primary completion
- Apr 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of dupilumab in coronavirus disease 2019 (COVID-19), sponsored by University of Virginia. Started May 2021; status: completed.
02
Drugs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04920916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04920916.